Evaluating the Efficacy and Safety of the Combination of Herombopag and Human Thrombopoietin (rhTPO) in the Treatment of Patients With Severe Immune Thrombocytopenia (ITP)
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Hetrombopag (Primary) ; Thrombopoietin (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
Most Recent Events
- 19 Apr 2022 New trial record